• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤细胞 p53 状态对外源和内源凋亡信号的影响。

Impact of the p53 status of tumor cells on extrinsic and intrinsic apoptosis signaling.

机构信息

Helmholtz Zentrum München, German Research Center for Environmental Health, Marchioninistrasse 25, Munich, D-81377, Germany.

出版信息

Cell Commun Signal. 2013 Apr 17;11(1):27. doi: 10.1186/1478-811X-11-27.

DOI:10.1186/1478-811X-11-27
PMID:23594441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3641951/
Abstract

BACKGROUND

The p53 protein is the best studied target in human cancer. For decades, p53 has been believed to act mainly as a tumor suppressor and by transcriptional regulation. Only recently, the complex and diverse function of p53 has attracted more attention. Using several molecular approaches, we studied the impact of different p53 variants on extrinsic and intrinsic apoptosis signaling.

RESULTS

We reproduced the previously published results within intrinsic apoptosis induction: while wild-type p53 promoted cell death, different p53 mutations reduced apoptosis sensitivity. The prediction of the impact of the p53 status on the extrinsic cell death induction was much more complex. The presence of p53 in tumor cell lines and primary xenograft tumor cells resulted in either augmented, unchanged or reduced cell death. The substitution of wild-type p53 by mutant p53 did not affect the extrinsic apoptosis inducing capacity.

CONCLUSIONS

In summary, we have identified a non-expected impact of p53 on extrinsic cell death induction. We suggest that the impact of the p53 status of tumor cells on extrinsic apoptosis signaling should be studied in detail especially in the context of therapeutic approaches that aim to restore p53 function to facilitate cell death via the extrinsic apoptosis pathway.

摘要

背景

p53 蛋白是人类癌症中研究最透彻的靶点。几十年来,人们一直认为 p53 主要作为肿瘤抑制因子发挥作用,并通过转录调控发挥作用。直到最近,p53 的复杂多样的功能才引起了更多的关注。我们使用几种分子方法研究了不同 p53 变体对外源和内源细胞凋亡信号的影响。

结果

我们重现了先前关于内源细胞凋亡诱导的研究结果:野生型 p53 促进细胞死亡,而不同的 p53 突变则降低了细胞对凋亡的敏感性。对 p53 状态对外源细胞死亡诱导影响的预测要复杂得多。肿瘤细胞系和原代异种移植肿瘤细胞中 p53 的存在导致细胞死亡增加、不变或减少。野生型 p53 被突变型 p53 取代并不影响外源细胞凋亡的诱导能力。

结论

总之,我们发现了 p53 对外源细胞死亡诱导的非预期影响。我们建议,特别是在旨在恢复 p53 功能以通过外源细胞凋亡途径促进细胞死亡的治疗方法的背景下,应详细研究肿瘤细胞 p53 状态对外源细胞凋亡信号的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a869/3641951/e9f1567d3b44/1478-811X-11-27-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a869/3641951/ba60bee2ea96/1478-811X-11-27-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a869/3641951/f15bfe3c64e3/1478-811X-11-27-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a869/3641951/559d952b459e/1478-811X-11-27-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a869/3641951/e9f1567d3b44/1478-811X-11-27-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a869/3641951/ba60bee2ea96/1478-811X-11-27-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a869/3641951/f15bfe3c64e3/1478-811X-11-27-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a869/3641951/559d952b459e/1478-811X-11-27-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a869/3641951/e9f1567d3b44/1478-811X-11-27-4.jpg

相似文献

1
Impact of the p53 status of tumor cells on extrinsic and intrinsic apoptosis signaling.肿瘤细胞 p53 状态对外源和内源凋亡信号的影响。
Cell Commun Signal. 2013 Apr 17;11(1):27. doi: 10.1186/1478-811X-11-27.
2
DDX3 regulates DNA damage-induced apoptosis and p53 stabilization.DDX3调节DNA损伤诱导的细胞凋亡和p53稳定化。
Biochim Biophys Acta. 2013 Jun;1833(6):1489-97. doi: 10.1016/j.bbamcr.2013.02.026. Epub 2013 Mar 5.
3
Sensitization of p53-mutated epithelial ovarian cancer to CD95-mediated apoptosis is synergistically induced by cisplatin pretreatment.顺铂预处理可协同诱导p53突变的上皮性卵巢癌对CD95介导的细胞凋亡的敏感性。
Mol Cancer Ther. 2007 Feb;6(2):762-72. doi: 10.1158/1535-7163.MCT-06-0357.
4
ERK mediated upregulation of death receptor 5 overcomes the lack of p53 functionality in the diaminothiazole DAT1 induced apoptosis in colon cancer models: efficiency of DAT1 in Ras-Raf mutated cells.ERK介导的死亡受体5上调克服了二氨基噻唑DAT1在结肠癌模型中诱导凋亡时p53功能的缺失:DAT1在Ras-Raf突变细胞中的效率
Mol Cancer. 2016 Mar 8;15:22. doi: 10.1186/s12943-016-0505-7.
5
Distinct p53-independent apoptotic cell death signalling pathways in testicular germ cell tumour cell lines.睾丸生殖细胞肿瘤细胞系中不同的不依赖p53的凋亡细胞死亡信号通路。
Int J Cancer. 1999 May 17;81(4):620-8. doi: 10.1002/(sici)1097-0215(19990517)81:4<620::aid-ijc19>3.0.co;2-s.
6
Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.重新激活p53并诱导肿瘤凋亡(RITA)增强RITA敏感型结肠癌细胞对化疗药物5-氟尿嘧啶和奥沙利铂的反应。
Neoplasia. 2017 Apr;19(4):301-309. doi: 10.1016/j.neo.2017.01.007. Epub 2017 Mar 9.
7
CDIP, a novel pro-apoptotic gene, regulates TNFalpha-mediated apoptosis in a p53-dependent manner.CDIP是一种新型促凋亡基因,以p53依赖的方式调节肿瘤坏死因子α介导的细胞凋亡。
EMBO J. 2007 Jul 25;26(14):3410-22. doi: 10.1038/sj.emboj.7601779. Epub 2007 Jun 28.
8
Knockdown of FAM3B triggers cell apoptosis through p53-dependent pathway.敲低 FAM3B 通过 p53 依赖性途径触发细胞凋亡。
Int J Biochem Cell Biol. 2013 Mar;45(3):684-91. doi: 10.1016/j.biocel.2012.12.003. Epub 2012 Dec 12.
9
Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.p53靶点在结肠癌对死亡配体疗法化疗增敏中的需求
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15095-100. doi: 10.1073/pnas.2435285100. Epub 2003 Nov 26.
10
Nutlin-3 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulation of death receptor 5 (DR5) in human sarcoma HOS cells and human colon cancer HCT116 cells.Nutlin-3 通过上调人骨肉瘤 HOS 细胞和人结肠癌细胞 HCT116 中的死亡受体 5(DR5)增强肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的细胞凋亡。
Cancer Lett. 2010 Jan 1;287(1):98-108. doi: 10.1016/j.canlet.2009.06.002. Epub 2009 Jul 3.

引用本文的文献

1
4-Furanylvinylquinoline derivative as a new scaffold for the design of oxidative stress initiator and glucose transporter inhibitor drugs.4-呋喃基乙烯基喹啉衍生物作为设计氧化应激引发剂和葡萄糖转运体抑制剂药物的新骨架。
Sci Rep. 2024 Nov 18;14(1):28454. doi: 10.1038/s41598-024-79698-0.
2
Characterization on the oncogenic effect of the missense mutations of p53 via machine learning.基于机器学习的 p53 错义突变致癌效应的特征分析。
Brief Bioinform. 2023 Nov 22;25(1). doi: 10.1093/bib/bbad428.
3
MHY2251, a New SIRT1 Inhibitor, Induces Apoptosis via JNK/p53 Pathway in HCT116 Human Colorectal Cancer Cells.

本文引用的文献

1
Enhanced anti-tumour effects of Vinca alkaloids given separately from cytostatic therapies.长春碱类药物与细胞毒性疗法分开使用时增强抗肿瘤作用。
Br J Pharmacol. 2013 Apr;168(7):1558-69. doi: 10.1111/bph.12068.
2
Next-generation cDNA screening for oncogene and resistance phenotypes.下一代 cDNA 筛选技术用于检测致癌基因和耐药表型。
PLoS One. 2012;7(11):e49201. doi: 10.1371/journal.pone.0049201. Epub 2012 Nov 7.
3
The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL.衔接蛋白 FADD 和起始半胱天冬酶-8 通过 TRAIL 介导 NF-κB 的激活。
新型SIRT1抑制剂MHY2251通过JNK/p53途径诱导HCT116人结肠癌细胞凋亡。
Biomol Ther (Seoul). 2023 Jan 1;31(1):73-81. doi: 10.4062/biomolther.2022.044. Epub 2022 Jul 11.
4
RMP/URI inhibits both intrinsic and extrinsic apoptosis through different signaling pathways.RMP/URI 通过不同的信号通路抑制内在型和外在型细胞凋亡。
Int J Biol Sci. 2019 Oct 15;15(12):2692-2706. doi: 10.7150/ijbs.36829. eCollection 2019.
5
Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells.p53 状态对 TRAIL 介导的癌细胞凋亡和非凋亡信号的影响。
PLoS One. 2019 Apr 4;14(4):e0214847. doi: 10.1371/journal.pone.0214847. eCollection 2019.
Cell Death Dis. 2012 Oct 25;3(10):e414. doi: 10.1038/cddis.2012.154.
4
NOXA as critical mediator for drug combinations in polychemotherapy.NOXA 作为多药化疗中药物联合的关键介质。
Cell Death Dis. 2012 Jun 21;3(6):e327. doi: 10.1038/cddis.2012.53.
5
Efficient RNA interference in patients' acute lymphoblastic leukemia cells amplified as xenografts in mice.在作为异种移植物扩增的小鼠患者急性淋巴细胞白血病细胞中进行有效的 RNA 干扰。
Cell Commun Signal. 2012 Mar 26;10(1):8. doi: 10.1186/1478-811X-10-8.
6
Important role of caspase-8 for chemosensitivity of ALL cells.半胱天冬酶-8 对 ALL 细胞化疗敏感性的重要作用。
Clin Cancer Res. 2011 Dec 15;17(24):7605-13. doi: 10.1158/1078-0432.CCR-11-0513. Epub 2011 Oct 18.
7
Optimized anti-tumor effects of anthracyclines plus Vinca alkaloids using a novel, mechanism-based application schedule.采用一种新型基于机制的应用方案优化蒽环类药物与长春碱类药物的抗肿瘤效果。
Blood. 2011 Dec 1;118(23):6123-31. doi: 10.1182/blood-2010-02-269811. Epub 2011 Sep 16.
8
Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.不同的 p53 转录程序决定了急性 DNA 损伤反应和肿瘤抑制。
Cell. 2011 May 13;145(4):571-83. doi: 10.1016/j.cell.2011.03.035.
9
The p53 pathway as a target in cancer therapeutics: obstacles and promise.p53 通路作为癌症治疗靶点:障碍与前景。
Sci Transl Med. 2011 Jan 5;3(64):64rv1. doi: 10.1126/scitranslmed.3001366.
10
The role of mutant p53 in human cancer.突变型 p53 在人类癌症中的作用。
J Pathol. 2011 Jan;223(2):116-26. doi: 10.1002/path.2784. Epub 2010 Oct 25.